SCHEMBL31009224

CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	NPY4R	P50391	15/20	0.51

▸	NPY1R	P25929	9/20	0.51

▸	NPY5R	Q15761	8/20	0.51

▸	NPY2R	P49146	5/20	0.51

▸	PTPN1	P18031	3/20	0.45

▸	EGFR	P00533	1/20	0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30905104	0.97	NPY4R (0.49)	NPY4RNPY1RNPY5RNPY2RPTPN1
SCHEMBL30525309	0.96	NPY4R (0.49)	NPY4RNPY1RNPY5RNPY2RPTPN1
SCHEMBL30905098	0.95	NPY4R (0.47)	NPY4RNPY1RNPY5RNPY2RPTPN1
SCHEMBL29883992	0.93	NPY4R (0.52)	NPY4RNPY1RNPY5RNPY2R
SCHEMBL31753635	0.93	NPY4R (0.52)	NPY4RNPY1RNPY5RNPY2R
SCHEMBL30837494	0.93	NPY4R (0.48)	NPY4RNPY1RNPY5RNPY2RPTPN1
SCHEMBL30007866	0.91	NPY4R (0.50)	NPY4RNPY1RNPY5RNPY2R
SCHEMBL31276953	0.91	NPY4R (0.49)	NPY4RNPY1RNPY5RNPY2R
SCHEMBL31157652	0.91	NPY4R (0.49)	NPY4RNPY1RNPY5RNPY2REGFR
SCHEMBL31571445	0.91	NPY4R (0.52)	NPY4RNPY1RNPY5RNPY2REGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3881861-B1	DOSAGE REGIMES FOR THE ADMINISTRATION OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES	ZEALAND PHARMA AS (DK)	2024-07-31	—	—	EP	claimed